Beam Therapeutics Inc
BEAM
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.36B
Close$
$-25.93
183.6% downside
Current Fair Value
183.6% downsideOvervalued by 183.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $3.36 Billion |
|---|---|
| Enterprise Value | $3.22 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.81 |
| Beta | 2.18 |
| Outstanding Shares | 103,262,000 |
Return
| Return on Equity | -5.59% |
|---|---|
| Return on Assets | -4.39% |
| Return on Invested Capital | -5.79% |
Valuation & Multiples
| P/E Ratio | -51.06 |
|---|---|
| PEG | 373.17 |
| Price to Sales | 31.0 |
| Price to Book Ratio | 2.82 |
| Enterprise Value to Revenue | 24.38 |
| Enterprise Value to EBIT | -39.63 |
| Enterprise Value to Net Income | -50 |
| Total Debt to Enterprise | 0.05 |
| Debt to Equity | 0.13 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 12, 2026
EPS Estimate
$-1.02
Average shareholder expectationRevenue Estimate
$11.11 M
Average shareholder expectationNext Earnings Call
Expected Date
August 4, 2026
EPS Estimate
$-1.11
Average shareholder expectationRevenue Estimate
$16.37 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 52.45% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.07%▼ 109.37% |
|---|---|
| Total Invested | $2.58M▼ 99.90% |
| Investors Holding | 9▼ 254.00% |
ESG Score
No data